dichlororibofuranosylbenzimidazole has been researched along with Aging in 1 studies
Dichlororibofuranosylbenzimidazole: An RNA polymerase II transcriptional inhibitor. This compound terminates transcription prematurely by selective inhibition of RNA synthesis. It is used in research to study underlying mechanisms of cellular regulation.
Aging: The gradual irreversible changes in structure and function of an organism that occur as a result of the passage of time.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ryu, SW | 1 |
| Woo, JH | 1 |
| Kim, YH | 1 |
| Lee, YS | 1 |
| Park, JW | 1 |
| Bae, YS | 1 |
1 other study available for dichlororibofuranosylbenzimidazole and Aging
| Article | Year |
|---|---|
Downregulation of protein kinase CKII is associated with cellular senescence.
Topics: Aging; Animals; Casein Kinase II; Cell Line; Cellular Senescence; Cyclin-Dependent Kinase Inhibitor | 2006 |